Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DurAVR™ THV EU-EFS

NCT: NCT06510855 · ACTIVE_NOT_RECRUITING

NCT IDNCT06510855
StatusACTIVE_NOT_RECRUITING
Start Date2025-01-21
SponsorAnteris Technologies Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑